These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25875733)

  • 1. Complex history of the discovery and characterization of congenital factor X deficiency.
    Girolami A; Cosi E; Sambado L; Girolami B; Randi ML
    Semin Thromb Hemost; 2015 Jun; 41(4):359-65. PubMed ID: 25875733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor X Friuli Coagulation Disorder: Almost 50 Years Later.
    Girolami A; Cosi E; Santarossa C; Ferrari S; Girolami B; Lombardi AM
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):33-40. PubMed ID: 28030967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X.
    Chafa O; Tagzirt M; Tapon-Bretaudière J; Reghis A; Fischer AM; LeBonniec BF
    Thromb Res; 2009 May; 124(1):144-8. PubMed ID: 19135706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era.
    Girolami A; Vettore S; Scarparo P; Lombardi AM
    Haemophilia; 2011 Jan; 17(1):17-20. PubMed ID: 20546029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Homozygous missense mutation p.Val298Met of F10 gene causing hereditary coagulation factor X deficiency in a Chinese pedigree].
    Jin Y; Hao X; Cheng X; Yang L; Chen Y; Xie H; Wang Y; Wang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Jun; 33(3):296-9. PubMed ID: 27264807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of Glu102Lys on the factor X function in a patient with a doubly homozygous factor X deficiency (Gla14Lys and Glu102Lys).
    Forberg E; Huhmann I; Jimenez-Boj E; Watzke HH
    Thromb Haemost; 2000 Feb; 83(2):234-8. PubMed ID: 10739379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years).
    Girolami A; Cosi E; Santarossa C; Ferrari S; Girolami B; Lombardi AM
    Eur J Haematol; 2016 Dec; 97(6):547-553. PubMed ID: 27124643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.
    Ding Q; Shen Y; Yang L; Wang X; Rezaie AR
    Thromb Haemost; 2013 Jul; 110(1):53-61. PubMed ID: 23677006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency.
    Pinotti M; Marchetti G; Baroni M; Cinotti F; Morfini M; Bernardi F
    Thromb Haemost; 2002 Aug; 88(2):236-41. PubMed ID: 12195695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired prothrombinase activity of factor X Gly381Asp results in severe familial CRM+ FX deficiency.
    Pinotti M; Camire RM; Baroni M; Rajab A; Marchetti G; Bernardi F
    Thromb Haemost; 2003 Feb; 89(2):243-8. PubMed ID: 12574802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and laboratory significance of cases of congenital FX deficiency due to defects in the Gla-domain.
    Girolami A; Allemand E; Scandellari R; Lombardi AM; Girolami B
    Hematology; 2009 Jun; 14(3):177-81. PubMed ID: 19490765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six novel missense mutations causing factor X deficiency and application of thrombin generation test.
    Liang Q; Chen Q; Ding Q; Wu F; Wang X; Xi X; Wang H
    Thromb Res; 2013 Jun; 131(6):554-9. PubMed ID: 23664564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor X Shanghai and disruption of translocation to the endoplasmic reticulum.
    Wang WB; Fu QH; Yin J; Wu WM; Ding QL; Zhou RF; Hu YQ; Wang XF; Wang ZY; Wang HL
    Haematologica; 2005 Dec; 90(12):1659-64. PubMed ID: 16330440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.
    Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
    Thromb Res; 2014 Nov; 134(5):1103-9. PubMed ID: 25179519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency.
    Bereczky Z; Bárdos H; Komáromi I; Kiss C; Haramura G; Ajzner E; Adány R; Muszbek L
    Haematologica; 2008 Feb; 93(2):299-302. PubMed ID: 18245654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of inherited factor X deficiency.
    Brown DL; Kouides PA
    Haemophilia; 2008 Nov; 14(6):1176-82. PubMed ID: 19141158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly.
    Al-Hilali A; Wulff K; Abdel-Razeq H; Saud KA; Al-Gaili F; Herrmann FH
    Thromb Haemost; 2007 Apr; 97(4):542-5. PubMed ID: 17393015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe factor X deficiency in three unrelated Palestinian patients is caused by homozygosity for the mutation c302delG-correlation with thrombin generation and thromboelastometry.
    Livnat T; Shenkman B; Kenet G; Tamarin I; Gillis S; Varon D; Iijima K; Zivelin A; Salomon O
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):673-9. PubMed ID: 22008904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain.
    Vianello F; Lombardi AM; Bello FD; Palù G; Zanon E; Girolami A
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):401-5. PubMed ID: 12945883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital FX Deficiency Rio Tercero: A New Heterozygous Missense Mutation (Cys241Gly) with a Potentiating Effect by a Polymorphism (c. 503-57C>T).
    Girolami A; Minoldo S; Ferrari S; Colussi D; Lombardi AM; Guglielmone H
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):136-141. PubMed ID: 28891452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.